Article

Joint Injections Don't Raise Bleeding Risk

It isn't necessary to reduce the level of anticoagulation before joint injections and aspiration, say researchers from the Regions Hospital in St. Paul, Minnesota, and the University of Minnesota in Minneapolis, Minnesota. The procedures can be done safely in patients on warfarin, without risk of increased bleeding.



 

Recommended Reading

FDA panels revisit rosiglitazone's cardiovascular safety
Clinician Reviews
Heparin-Induced Thrombocytopenia
Clinician Reviews
Failure to Identify Blockage During Catheterization
Clinician Reviews
A Medical Condition - or Psychiatric?
Clinician Reviews
Grad Student With Palpitations
Clinician Reviews
Drug Abuse Follows a Broken Heart
Clinician Reviews
Is Active Patient a “Picture of Health”?
Clinician Reviews
Excessive visceral fat linked to increased risk of CVD, cancer
Clinician Reviews
FDA panel supports easing rosiglitazone restrictions
Clinician Reviews
Do Asymptomatic Adults Need Screening EKGs?
Clinician Reviews